1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Maintenance use is more important than the choice of bortezomib-based triplet induction in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation
    Meeting Abstract

    Sidana, S.; Kumar, S. K.; Fraser, R.; Estrada-Merly, N.; Norkin, M.; Giralt, S.; Qazilbash, M. H.; Shah, N.; D'Souza, A.
    Blood (2020)

    Fulltext@MSK | Save
  • Bridging the gap in access to transplant for underserved minority patients using mismatched unrelated donors and post-transplant cyclophosphamide: A National Marrow Donor Program/Be The Match (NMDP/BTM) Initiative
    Meeting Abstract

    Shaw, B. E.; Jimenez-Jimenez, A.; Burns, L. J.; Logan, B.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Opposing evolutionary pressures drive clonal evolution and health outcomes in the aging blood system
    Meeting Abstract

    Skead, K.; Houle, A. A.; Abelson, S.; Fave, M. J.; Lin, B.; Soave, D.; Wright, S.; Dick, J. E.; Morris, Q.; Awadalla, P.
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: Updated results of a phase Ib/II randomized study and preliminary results of a single-arm extension
    Meeting Abstract

    Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S. E.; Flowers, C.; Kim, T. M.; McMillan, A.; Ozcan, M.; Safar, V.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Results of a phase 1 open label dose escalation trial of AB-205 (allogeneic engineered endothelial cell therapy) in adults with lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (HDT-AHCT)
    Meeting Abstract

    Scordo, M.; Budde, L. E.; Abedi, M.; Mulroney, C.; Fakhri, B.; Pawarode, A.; Dholaria, B.; Kavalerchik, E.; Aggarwal, S. K.; Qazilbash, M. H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders: A population based study including 94,579 cases and 368,348 matched controls
    Meeting Abstract

    Shah, U. A.; Rögnvaldsson, S.; Derkach, A.; Björkholm, M.; Turesson, I.; David, Y.; Hultcrantz, M.; Tan, C.; Hassoun, H.; Korde, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma: Primary efficacy and safety analysis of the phase 2 CheckMate 436 study
    Meeting Abstract

    Santoro, A.; Moskowitz, A. J.; Ferrari, S.; Carlo-Stella, C.; Fanale, M. A.; Francis, S.; Sacchi, M.; Savage, K. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Outcomes of patients with relapsed mantle cell lymphoma treated with venetoclax: A multicenter retrospective analysis
    Meeting Abstract

    Sawalha, Y.; Goyal, S.; Switchenko, J. M.; Romancik, J. T.; Kamdar, M.; Greenwell, I. B.; Hess, B. T.; Isaac, K.; Portell, C. A.; Garcia, A. V. M.; more...
    Blood (2020)

    Fulltext@MSK | Save